相关实验视频

Updated: Jul 19, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

KDM4C和GFPT1:对于胃癌的潜在治疗标

Chenkai Li¹, Yunqian Chu², Hanjue Dai²

¹Department of Science and Technology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, 213003 Changzhou, Jiangsu, China.

Discovery medicine

|December 27, 2024

概括

氨酸脱甲基酶4C (KDM4C) 通过上调谷氨酸果糖-6-酸盐转胺酶1 (GFPT1) 促进胃癌的进展. 这项研究揭示了减缓胃癌进展的新治疗标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

胃癌的检测和治疗需要了解其发展途径.
研究谷氨酸果糖-6-酸盐转胺酶1 (GFPT1) 和氨酸脱甲基酶4C (KDM4C) 在胃癌进展中的作用至关重要.

研究的目的:

阐明胃癌中GFPT1和KDM4C之间的调节关系.
确定GFPT1和KDM4C对胃癌细胞表型的影响.

主要方法:

生物信息学分析预测GFPT1和KDM4C水平和相关性.
定量实时聚合酶链反应 (qRT-PCR) 用于基因表达分析.
细胞活力 (CCK-8),增殖 (殖民地形成),迁移,入侵 (Transwell) 和血管仿真 (管形成) 的测试.
对蛋白质表达的西方斑点分析,包括GFPT1和与上皮介质转变 (EMT) 相关的标记物.

主要成果:

在胃癌细胞中,GFPT1的表达很高,促进活力,增殖,迁移,入侵,血管仿真和EMT.
在胃癌中,KDM4C与GFPT1正相关.
过度表达KDM4C增强了GFPT1的表达及其促癌效应,而KDM4C倒置则逆转了这些效应.
KDM4C和GFPT1表达水平之间的相互作用相互调节的胃癌细胞表型.

结论:

KDM4C积极调节GFPT1,推动胃癌的进展.
KDM4C-GFPT1轴代表了抑制胃癌的潜在治疗标.
准这种途径可能提供一种新的策略来减缓胃癌的进展.

关键词:

氨酸脱甲基酶 4C 氨酸脱甲基酶表皮细胞-介质细胞过渡.胃癌胃癌是一种胃癌.谷氨酸-果糖-6-酸盐转胺酶1 血管生成的模仿

更多相关视频

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...